Sodium-Glucose Co-Transporter 2 Inhibitors Reduce Macular Edema in Patients with Diabetes mellitus

Purpose: To determine the efficacy of systemic sodium-glucose co-transporter 2 inhibitors (SGLT2i) on diabetic macular edema (DME). Methods: The medical records of patients with DME with a central retinal thickness (CRT) ≥320 µm in men and 305 µm in women, more than 6 months after the initiation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatsumi, Tomoaki, Oshitari, Toshiyuki, Takatsuna, Yoko, Ishibashi, Ryoichi, Koshizaka, Masaya, Shiko, Yuki, Baba, Takayuki, Yokote, Koutaro, Yamamoto, Shuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146993/
https://www.ncbi.nlm.nih.gov/pubmed/35629361
http://dx.doi.org/10.3390/life12050692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146993/
https://www.ncbi.nlm.nih.gov/pubmed/35629361
http://dx.doi.org/10.3390/life12050692

Ejemplares similares